American Society of Hematology

MDS+AML MATTER Summit Schedule & Program

Please note that start and end times for each summit vary by location. Visit the MDS+AML MATTER website to learn more.


15 minutes
Welcome, Introductions, and Summit Overview
1 hour, 30 minutes
Tumor Board Presentation of MDS and AML
Faculty will identify a clinical case in which MDS transforms into AML and will lead a discussion on the case using a tumor board format. An audience response system will allow participants to respond to polling questions in real time. After the case discussion, faculty will review optimal diagnostic and treatment choices.
15 minutes
Break
2 hours
Breakout Sessions
Participants will rotate through four 30-minute breakout sessions on the following topics:
  • Diagnosis of myeloid neoplasms, including morphology, cytogenetic, and molecular testing
  • Treatment decision-making/management for MDS
  • Treatment decision-making/management for AML
  • The role of minimal residual disease and transplant in MDS and AML

Discussions will focus on bone marrow specimen retrieval and preparation, testing algorithms, interpretation of testing results, classification and risk stratification of both MDS and AML, optimal timing for a referral to hematopoietic cell transplantation (HCT), and other considerations for eligibility for HCT.

30 minutes
Lunch (featuring The Patient Voice)
To incorporate the patient/caregiver perspective, during lunch participants will hear from two MDS and/or AML patients or caregivers. These individuals will share their stories to create the framework and context on surrounding issues that are most important to them (e.g., educational needs and psychosocial challenges).
1 hour
Practice-Based Learning
Participants will be assigned to small, interdisciplinary workgroups. Each group will be given a case and will need to create a tumor board session based on the assigned case, which will include images and actual pathology reports. The discussion will cover challenging diagnoses that may elude confirmation and may be cofounded by comorbidities, clinical case scenarios that call for risk-adapted treatment selection, and situations that call for interdisciplinary communication regarding tissue acquisition, ordering tests, and reporting test results.
1 hour
Workgroup Presentations and Q&A
Each workgroup will present its patient care plan to the audience for feedback and discussion. Faculty will assess and evaluate each group’s presentation.
15 minutes
Learners Discuss Key Takeaways and Develop Action Plans
Participants will revisit the key challenges identified at the beginning of the program, discuss what they have learned, and develop an action plan for incorporating the new knowledge and competence into practice.
15 minutes
Post-Activity Survey, Evaluations, and Summit Wrap-Up
back to top